Abiopharma

Receipt of an order of approximately $1.3 million from a customer in Europe, to be supplied in Q2 2027

Publication date of the Q2 2026 report on 27.8.26, conference call time: 18:30

Receipt of an order in a financial scope of approximately US$1.3 million, from a customer in Asia. Will be supplied in Q2 2026

Became an interested party - HAPHOENIX FINANCE LTD - supplementary report

Became an interested party – The Phoenix Investment House Ltd. – report amendment

Became an interested party – Phoenix Finance Ltd.

Register of shareholders, changes and share capital status – exercise of warrants into shares and private placement

Holdings of interested parties/officers as of 30.6.26

Notice of a special meeting for 14.7.26 – amendment – removal of the reference to an exemption within the framework of the terms of office of the appointed directors

Dormant shares - change in the number of shares